The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Open accessPublished version of a preprint
Abstract
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-γ-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4+ and/or CD8+ epitopes, including six immunodominant regions. Six optimized CD8+ epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8+ T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredIn the citing paper
“By contrast, VAERD has not usually occurred if a TH1 cell-biased CD4+ T cell response is elicited, reflected by increased levels of interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF)44–46,49.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [46]
In the citing paper
“Robust CD4+ and CD8+ T cell memory is induced after COVID-19,22,39, 40, 41 and multiple COVID-19 vaccines elicit CD4+ and CD8+ T cell responses.26,42, 43, 44, 45”
From Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals (2021) · cites this paper as [40]
In the citing paper
“It should be noted that all plasma and sera tested completely inhibited entry at the lowest dilution tested and that T cell responses will contribute to control of SARS-CoV-2 infection, particularly in re-infected convalescent patients (Grifoni et al., 2020; Peng et al., 2020).”
From SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) · cites this paper as Peng et al., 2020
In the citing paper
“T cell responses are detected after almost all SARS-CoV-2 infections (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Peng et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“In SARS-CoV-2 infections, the presence of virus-specific CD8+ T cells has been associated with better COVID-19 outcomes (Rydyznski Moderbacher et al., 2020; Peng et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“Current evidence suggests an early, robust, and diverse T cell response directed against SARS-CoV-2 correlates with milder COVID-19 outcomes126,131,132”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“Severe COVID-19 has been associated with lower TCR diversity against SARS-CoV-2 epitopes131,132.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“For CD8+ T cells, there are reports of diminished CD8+ cytotoxicity and cytokine production in severe cases126,132, while others report the opposite141, and still others find no differences142.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Self-citationFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citation
Research works printed but not linked: 1
- Fehr, A. R. & Perlman, S. in Coronaviruses. Methods in Molecular Biology Vol. 1282 (eds Maier H., Bickerton E., Britton P.) 1–23 (Humana Press, 2015).
Cited by
Sorted by citations
Items 401–500 of 1,000
van de Ven, K., van Dijken, H., Wijsman, L. A., Gomersbach, A., Schouten, T., Kool, J., Lenz, S., Roholl, P. J. M., Meijer, A., van Kasteren, P. B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750229 · Cited by 26
Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
Rea, I. M., & Alexander, H. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101494 · Cited by 27
Cortés, A., Casado, J., Longo, F., Serrano, J. J., Saavedra, C., Velasco, H., Martín, A., Chamorro, J., Rosero, D., Fernández, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.02.017 · Cited by 25
Rajamanickam, A., Kumar, N. P., Pandiaraj, A. N., Selvaraj, N., Munisankar, S., Renji, R. M., Venkataramani, V., Murhekar, M., Thangaraj, J. W. V., Muthusamy, S. K., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5cova0721-392rr · Cited by 28
Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Dockrell, H. M., & McShane, H. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103993 · Cited by 27
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2
Titov, A., Shaikhutdinova, R., Shcherbakova, O. V., Serdyuk, Y. V., Sheetikov, S. A., Zornikova, K. V., Maleeva, A. V., Khmelevskaya, A. A., Dianov, D. V., Shakirova, N. T., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.157699 · Cited by 26
Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity
Beserra, D. R., Alberca, R. W., Branco, A. C. C. C., Oliveira, L. D. M., Andrade, M. M. D. S., Gozzi-Silva, S. C., Teixeira, F. M. E., Yendo, T. M., Duarte, A. J. D. S., & Sato, M. N. (2022) · Journal of Immunology Research · doi:10.1155/2022/9764002 · Cited by 30
Wang, J., Deng, C., Liu, M., Liu, Y., Li, L., Huang, Z., Shang, L., Jiang, J., Li, Y., Mo, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34633-7 · Cited by 45
Yu, M., Charles, A., Cagigi, A., Christ, W., Österberg, B., Falck‐Jones, S., Azizmohammadi, L., Åhlberg, E., Falck‐Jones, R., Svensson, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37835-9 · Cited by 29
Mok, C. K. P., Chen, C., Zhao, S., Sun, Y., Yiu, K. K. L., Chan, T., Lai, H.-L., Lai, K. C., Lau, K. M., Ling, K. C., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00006-x · Cited by 25
Kared, H., Redd, A. D., Bloch, E. M., Bonny, T. S., Sumatoh, H., Kairi, F., Carbajo, D., Abel, B., Newell, E. W., Bettinotti, M. P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.08.330688 · Cited by 27
Ye, Z., Bonam, S. R., McKay, L. G. A., Plante, J. A., Walker, J. L., Zhao, Y., Huang, C., Chen, J., Xu, C., Li, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311752120 · Cited by 25
Self-citationAn Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19?
Zhao, S., Xie, T., Shen, L. W., Liu, H., Wang, L., Ma, X., Wu, J., Yuan, S., Mor, G., & Liao, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631044 · Cited by 25
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
Banerjee, A., Ganguly, U., Saha, S., Chakrabarti, S., Saini, R. V., Rawal, R. K., Saso, L., & Chakrabarti, S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1905519 · Cited by 27
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Maecker, H. T. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002550 · Cited by 26
Vaccination reshapes the virus-specific T cell repertoire in unexposed adults
Pan, Y., Aiamkitsumrit, B., Bartolo, L., Wang, Y., Lavery, C. L. M., Marc, A., Holec, P. V., Rappazzo, C. G., Eilola, T., Gimotty, P. A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.023 · Cited by 29
Yang, L., Zhou, M. L., Li, L., Luo, P., Fan, W., Xu, J., Chen, Q., Pan, F., Lei, P., Zheng, C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01426-3 · Cited by 27
Adam, L., Rosenbaum, P., Quentric, P., Parizot, C., Bonduelle, O., Guillou, N., Corneau, A., Dorgham, K., Miyara, M., Luyt, C. E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151571 · Cited by 25
Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report
Racette, S. D., Alexiev, B. A., Angarone, M., Bhasin, A., Lima, K., Jennings, L. J., Balasubramanian, S. S., & Matsuoka, A. J. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06048-0 · Cited by 26
T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants
Nguyen, T. H. O., Cohen, C. A., Rowntree, L. C., Bull, M. B., Hachim, A., Kedzierska, K., & Valkenburg, S. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.793102 · Cited by 24
Rosa, S. C. D., Cohen, K. W., Bonaparte, M. I., Fu, B., Garg, S., Gerard, C. M., Goepfert, P., Huang, Y., Larocque, D., McElrath, M. J., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1360 · Cited by 27
Marty, P. K., Keulen, V. P. V., Erskine, C. L., Shah, M., Hummel, A. M., Stachowitz, M., Fatis, S., Granger, D., Block, M. S., Duarte‐García, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834981 · Cited by 26
Chen, J., Deng, Y. L., Huang, B., Han, D., Wang, W., Huang, M., Zhai, C., Zhao, Z., Yang, R., Zhao, Y. H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.827605 · Cited by 26
Self-citationFerrantelli, F., Chiozzini, C., Manfredi, F., Leone, P., Spada, M., Virgilio, A. D., Giovannelli, A., Sanchez, M., Cara, A., Michelini, Z., et al. (2022) · Viruses · doi:10.3390/v14020329 · Cited by 25
Bačová, B., Kohutová, Z., Zubata, I. K., Gahérová, Ľ., Kučera, P., Heizer, T., Mikesova, M., Karel, T., & Novák, J. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00809-0 · Cited by 26
Vasileiou, S., Hill, L. C., Kuvalekar, M., Workineh, A. G., Watanabe, A., Velazquez, Y., Lulla, S., Mooney, K., Lapteva, N., Grilley, B., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281946 · Cited by 26
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Sunagar, R., Singh, A., & Kumar, S. (2023) · Vaccines · doi:10.3390/vaccines11040849 · Cited by 31
Yang, H., Sun, H., Brackenridge, S., Zhuang, X. A., Wing, P. A. C., Quastel, M. N., Walters, L. C., Garner, L. I., Wang, B., Yao, X., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abl8881 · Cited by 26
Self-citationOverview of Nucleocapsid-Targeting Vaccines against COVID-19
Rak, A. Y., Николаевна, И.-С. И., & Георгиевна, Р. Л. (2023) · Vaccines · doi:10.3390/vaccines11121810 · Cited by 26
Leekha, A., Saeedi, A., Sefat, K. M. S. R., Kumar, M., Martinez-Paniagua, M. A., Damian, A., Kulkarni, R. S., Reichel, K., Rezvan, A., Masoumi, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50133-2 · Cited by 25
Yim, J., Lim, H. H., & Kwon, Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01331-9 · Cited by 26
Xu, K., An, Y., Li, Q., Huang, W., Han, Y., Zheng, T., Fang, F., Liu, H., Liu, C., Gao, P., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1959270 · Cited by 25
Self-citationScurr, M. J., Zelek, W. M., Lippiatt, G., Somerville, M. S., Burnell, S. E. A., Capitani, L., Davies, K., Lawton, H., Tozer, T., Rees, T., et al. (2021) · Immunology · doi:10.1111/imm.13433 · Cited by 24
Li, L., Müftüoğlu, M., Liang, S., Basyal, M., Lv, J., Akdogan, M. E., Chen, K., Andreeff, M., Flowers, C. R., & Parmar, S. (2022) · JCI Insight · doi:10.1172/jci.insight.156559 · Cited by 24
Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence
Papadopoulou, G., Manoloudi, E., Repousi, N., Skoura, L., Hurst, T. P., & Karamitros, T. (2022) · Pathogens · doi:10.3390/pathogens11030311 · Cited by 25
Obermair, F.-J., Renoux, F., Heer, S., Lee, C. H.-J., Cereghetti, N., Loi, M., Maestri, G., Haldner, Y., Wuigk, R., Iosefson, O., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl5394 · Cited by 26
Gupta, S., Agrawal, S., Sandoval, A., Su, H., Tran, M., & Demirdağ, Y. Y. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01256-y · Cited by 25
Rovito, R., Bono, V., Augello, M., Tincati, C., Mainoldi, F., Beaudoin-Bussières, G., Tauzin, A., Bianchi, S., Hadla, M., Yellenki, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23923-1 · Cited by 25
Current understanding of T cell immunity against SARS-CoV-2
Lu, X., & Yamasaki, S. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00242-6 · Cited by 23
Mitigation of influenza-mediated inflammation by immunomodulatory matrix-bound nanovesicles
Crum, R. J., Huckestien, B. R., Dwyer, G., Mathews, L., Nascari, D. G., Hussey, G. S., Turnquist, H. R., Alcorn, J. F., & Badylak, S. F. (2023) · Science Advances · doi:10.1126/sciadv.adf9016 · Cited by 25
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults
Samandari, T., Ongalo, J., McCarthy, K. D., Biegon, R., Madiega, P. A., Mithika, A., Orinda, J., Mboya, G., Mwaura, P., Anzala, O. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170011 · Cited by 24
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Pi, P., Zeng, Z., Zeng, L., Han, B., Bai, X., & Xu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1218059 · Cited by 29
Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins
Devi, Y. D., Goswami, H. B., Konwar, S., Doley, C., Dolley, A., Devi, A., Chongtham, C., Dowerah, D., Biswa, V., Jamir, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258645 · Cited by 25
SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients
Gurevich, M., Zilkha‐Falb, R., Sonis, P., Magalashvili, D., Menascu, S., Flechter, S., Dolev, M., Mandel, M., & Achiron, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.12.309 · Cited by 24
Zhou, S., Zhang, R., Zhang, H.-W., Liu, Y., Wen, Y., Wang, J., Li, Y., You, Z.-W., Yin, X., Qiu, H. Y., et al. (2022) · Chemical Communications · doi:10.1039/d1cc06520c · Cited by 24
Pitcovski, J., Gruzdev, N., Abzach, A., Katz, C., Ben‐Adiva, R., Shwartz, M. B., Yadid, I., Ratzon-Ashkenazi, E., Emquies, K., Israeli, H., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.01.025 · Cited by 24
Paramithiotis, E., Sugden, S., Papp, E., Bonhomme, M., Chermak, T., Crawford, S. Y., Demetriades, S. Z., Galdos, G., Lambert, B. L., Mattison, J. E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880784 · Cited by 25
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Mullender, C., da Costa, K., Alrubayyi, A., Pett, S. L., & Peppa, D. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac005 · Cited by 23
Khatamzas, E., Antwerpen, M. H., Rehn, A., Graf, A., Hellmuth, J. C., Hollaus, A., Mohr, A., Gaitzsch, E., Weiglein, T., Georgi, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32772-5 · Cited by 22
Maghsood, F., Vanan, A. G., Yadegari, H., Golsaz‐Shirazi, F., Amiri, M. M., & Shokri, F. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2431 · Cited by 25
Nguyen, T. H. O., Rowntree, L. C., Allen, L. F., Chua, B. Y. L., Kedzierski, Ł., Lim, C., Lasica, M., Tennakoon, S., Saunders, N. R., Crane, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101017 · Cited by 25
Sarıkaya, Z. T., Güçyetmez, B., Kocagöz, A. S., Telci, L., & Akıncı, İ. Ö. (2023) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.4274/tjar.2022.22959 · Cited by 23
Yang, J., Zhong, M., Hong, K., Yang, Q., Zhang, E., Zhou, D., Xia, J., Chen, Y., Sun, M., Zhao, B., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1259 · Cited by 24
Self-citationVirological and immunological features of SARS‐COV‐2 infected children with distinct symptomatology
Cotugno, N., Ruggiero, A., Pascucci, G. R., Bonfante, F., Petrara, M. R., Zicari, S., Cifaldi, L., Zangari, P., Bernardi, S., Cursi, L., et al. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13585 · Cited by 22
Racine‐Brzostek, S., Yee, J. K., Sukhu, A. C., Qiu, Y., Rand, S., Barone, P. D., Hao, Y., Yang, H. S., Meng, Q. H., Apple, F. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151477 · Cited by 25
Immune interventions in COVID-19: a matter of time?
Plaçais, L., Richier, Q., Noël, N., Lacombe, K., Mariette, X., & Hermine, O. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00464-w · Cited by 22
HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses
Buckley, P. R., Lee, C. H.-J., Pinho, M. P., Babu, R. O., Woo, J., Antanaviciute, A., Simmons, A., Ogg, G. S., & Koohy, H. (2022) · Immunology · doi:10.1111/imm.13451 · Cited by 22
Self-citationThe immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic
Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 22
van den Dijssel, J., Hagen, R. R., de Jongh, R., Steenhuis, M., Rispens, T., Geerdes, D. M., Mok, J. Y., Kragten, A. H., Duurland, M. C., Verstegen, N. J. M., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1423 · Cited by 24
Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
O’Donnell, K. L., Gourdine, T., Fletcher, P., Clancy, C. S., & Marzi, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1025500 · Cited by 22
Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients
Kwiecień, I., Rutkowska, E., Kłos, K., Więsik–Szewczyk, E., Jahnz‐Różyk, K., Rzepecki, P., & Chciałowski, A. (2020) · Cells · doi:10.3390/cells9122615 · Cited by 23
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Tsagkli, P., Geropeppa, M., Papadatou, I., & Spoulou, V. I. (2024) · Vaccines · doi:10.3390/vaccines12091051 · Cited by 24
The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes
Tong, Z. W. M., Grant, E. J., Gras, S., Wu, M., Smith, C., Barrett, H. L., Gallo, L. A., & Short, K. R. (2021) · FEBS Journal · doi:10.1111/febs.16105 · Cited by 23
Sarzani, R., Spannella, F., Giulietti, F., Pentima, C. D., Giordano, P., & Giacometti, A. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02860-3 · Cited by 22
Conway, S. R., Lazarski, C. A., Field, N. E., Jensen-Wachspress, M. A., Lang, H., Kankate, V. V., Durkee-Shock, J. R., Kinoshita, H., Suslovic, W., Webber, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.793197 · Cited by 21
Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing
Zhao, P., Zou, J., Zhou, F., Zhu, Y., Song, Q., Yu, D., & Li, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108767 · Cited by 21
Ahmed, M. B., Bellali, H., Gdoura, M., Zamali, I., Kallala, O., Hmid, A. B., Hamdi, W., Ayari, H., Fares, H., Mechri, K., et al. (2022) · Vaccines · doi:10.3390/vaccines10081189 · Cited by 22
Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
Kakkassery, H., Carpenter, E., Patten, P., & Irshad, S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.07.006 · Cited by 23
Lai, G., Liu, H., Deng, J., Li, K., & Xie, B. (2022) · Genes · doi:10.3390/genes13091602 · Cited by 22
Stewart, E. L., Counoupas, C., Johansen, M. D., Nguyen, D. H., Miemczyk, S., Hansbro, N. G., Ferrell, K. C., Ashhurst, A. S., Alca, S., Ashley, C. L., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00578-9 · Cited by 23
Hvidt, A. K., Guo, H., Andersen, R., Nielsen, S. S. F., Vibholm, L. K., Søgaard, O. S., Schleimann, M. H., Russell, V. R., Cheung, A. M., Paramithiotis, E., et al. (2023) · BMC Immunology · doi:10.1186/s12865-023-00583-y · Cited by 21
Beijnen, E. M. S., & van Haren, S. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607977 · Cited by 22
Complement Activation Induces Excessive T Cell Cytotoxicity in Severe COVID-19Preprint
Georg, P., Astaburuaga-García, R., Bonaguro, L., Brumhard, S., Michalick, L., Lippert, L. J., Kostevc, T., Gäbel, C., Schneider, M., Streitz, M., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3866835 · Cited by 22
Charilaou, P., Tricarico, C. J., Battat, R. J., Scherl, E., Longman, R., & Lukin, D. J. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.007 · Cited by 21
Sala, L. L., Gandini, S., Bruno, A., Allevi, R., Gallazzi, M., Senesi, P., Palano, M. T., Meregalli, P., Longhi, E., Sommese, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.798813 · Cited by 23
Zhang, R., Shin, B., Gadsden, T. M., Petrosyan, A., Vo, A. A., Ammerman, N., Sethi, S., Huang, E., Peng, A., Najjar, R., et al. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13813 · Cited by 20
Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
Sieber, J., Mayer, M., Schmidthaler, K., Kopanja, S., Camp, J. V., Popovitsch, A., Dwivedi, V., Hoz, J., Schoof, A., Weseslindtner, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.882456 · Cited by 21
Sedegah, M., Porter, C. K., Goguet, E., Ganeshan, H. D., Belmonte, M., Huang, J., Belmonte, A. D., Inoue, S., Acheampong, N., Malloy, A. M. W., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276241 · Cited by 22
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
Bessen, C., Plaza‐Sirvent, C., Simsek, A., Bhat, J., Marheinecke, C. S., Urlaub, D., Bonowitz, P., Buße, S., Schumann, S., Blanco, E. V., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049070 · Cited by 23
Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity
Wu, D., Efimov, G. A., Васильевна, Б. А., Pierce, B. G., & Mariuzza, R. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103035 · Cited by 23
Yang, G., Wang, J., Sun, P., Qin, J., Yang, X., Chen, D., Zhang, Y., Zhong, N. S., & Wang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146196 · Cited by 23
Self-citationWussow, F., Kha, M., Kim, T. H., Ly, M., Yll, M., Kar, S., Lewis, M. G., Chiuppesi, F., & Diamond, D. J. (2023) · npj Vaccines · doi:10.1038/s41541-023-00640-y · Cited by 22
Vázquez‐Alejo, E., Tarancón‐Díez, L., Espinar-Buitrago, M. D. L. S., Genebat, M., Calderón, A., Pérez-Cabeza, G., Magro-López, E., Leal, M., & Muñoz‐Fernández, M. Á. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103539 · Cited by 21
Chen, Y., Mason, G. H., Scourfield, D. O., Greenshields‐Watson, A., Haigh, T. A., Sewell, A. K., Long, H. M., Gallimore, A., Rizkallah, P. J., MacLachlan, B. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112827 · Cited by 23
Self-citationCoulon, P.-G. A., Prakash, S., Dhanushkodi, N. R., Srivastava, R., Zayou, L., Tifrea, D. F., Edwards, R. A., Figueroa, C. J., Schubl, S. D., Hsieh, L. L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343716 · Cited by 20
Zelba, H., Worbs, D., Harter, J., Pieper, N., Kyzirakos, C., Kayser, S., Seibold, M., Bartsch, O., Ködding, J., & Biskup, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000811 · Cited by 21
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2Preprint
Wilson, P. C., Stamper, C. T., Dugan, H. L., Li, L., Asby, N. W., Halfmann, P., Guthmiller, J. J., Zheng, N., Huang, M., Stovicek, O., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-80476/v1 · Cited by 20
Kyei-Barffour, I., Akwetey, S. A., Aninagyei, E., Ghartey‐Kwansah, G., & Acheampong, D. O. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112282 · Cited by 21
Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes
Li, M., Zeng, J., Li, R., Wen, Z., Cai, Y., Wallin, J. J., Shu, Y., Du, X., & Sun, C. (2021) · Viruses · doi:10.3390/v13020333 · Cited by 20
T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
Fernández‐Ruiz, M., Olea, B., Almendro-Vázquez, P., Giménez, E., Marcacuzco, A., Juan, R. S., Justo, I., Calvo, J., García‐Sesma, Á., Manrique, A., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16708 · Cited by 22
Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
Jung, M. K., & Shin, E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0079 · Cited by 19
Hussain, A., Rafeeq, H., Asif, H. M., Shabbir, S., Bilal, M., Mulla, S. I., Franco, M., & Iqbal, H. M. N. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108050 · Cited by 20
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
Law, J. C., Girard, M., Chao, G. Y. C., Ward, L. A., Isho, B., Rathod, B., Colwill, K., Li, Z., Rini, J. M., Yue, F. Y., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100727 · Cited by 23
Vitamin D can reduce severity in COVID-19 through regulation of PD-L1
Aygün, H. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02210-w · Cited by 20
Tian, D., Song, Y., Zhang, M., Pan, Y., Ge, Z., Zhang, Y., Ren, X., Wen, J., Xu, Y., Guo, H., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27636 · Cited by 18
Self-citationHeterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
Eggenhuizen, P. J., Ng, B. H., Chang, J., Cheong, R. M. Y., Yellapragada, A., Wong, W. Y., Ting, Y. T., Monk, J. A., Gan, P., Holdsworth, S. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821595 · Cited by 20
Peter, L., Wendering, D. J., Schlickeiser, S., Hoffmann, H., Noster, R., Wagner, D. L., Zarrinrad, G., Münch, S., Picht, S., Schulenberg, S., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.02.012 · Cited by 19
Wang, C., Yang, S., Duan, L., Du, X., Tao, J., Wang, Y., Yang, J., Lv, Y., Li, J., Zhang, C., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01957-1 · Cited by 19
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Wing, P. A. C., Schmidt, N. M., Peters, R., Erdmann, M., Brown, R. L., Wang, H., Swadling, L., COVIDsortium Investigators, Newman, J., Thakur, N., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011323 · Cited by 23
Santiago-Carvalho, I., Santos, G. D. A., Macedo, B. D. G., Bomfim, C. C. B., Almeida, F. M., Cione, M. V. P., Vardam-Kaur, T., Masuda, M. Y., van Dijk, S., de Melo, B. M. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113448 · Cited by 20
Metadata
- Authors
- Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., López-Camacho, C., Slon-Campos, J., Zhao, Y., Stuart, D. I., Paesen, G. C., Grimes, J. M., Antson, A. A., Bayfield, O. W., Hawkins, D. E. D. P., Ker, D.-S., Wang, B., Turtle, L., Subramaniam, K., Thomson, P., Zhang, P., Dold, C., Ratcliff, J., Simmonds, P., de Silva, T., Sopp, P., Wellington, D., Rajapaksa, U., Chen, Y.-L., Salio, M., Napolitani, G., Paes, W., Borrow, P., Kessler, B. M., Fry, J. W., Schwabe, N. F., Semple, M. G., Baillie, J. K., Moore, S. C., Openshaw, P. J. M., Ansari, M. A., Dunachie, S., Barnes, E., Frater, J., Kerr, G., Goulder, P., Lockett, T., Levin, R., Zhang, Y., Jing, R., Ho, L.-P., Oxford Immunology Network Covid-19 Response T cell Consortium, Barnes, E., Dong, D., Dong, T., Dunachie, S., Frater, J., Goulder, P., Kerr, G., Klenerman, P., Liu, G., McMichael, A., Napolitani, G., Ogg, G., Peng, Y., Salio, M., Yao, X., Yin, Z., ISARIC4C Investigators, Kenneth Baillie, J., Klenerman, P., Mentzer, A. J., Moore, S. C., Openshaw, P. J. M., Semple, M. G., Stuart, D. I., Turtle, L., Cornall, R. J., Conlon, C. P., Klenerman, P., Screaton, G. R., Mongkolsapaya, J., McMichael, A., Knight, J. C., Ogg, G., & Dong, T.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- University of York (GB)
- University of Liverpool (GB)
- University of Sheffield (GB)
- ProImmune (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- Worthing Hospital (GB)
- Capital Medical University (CN)
- University of Edinburgh (GB)
- Siriraj Hospital (TH)
- ORCID
- Dejnirattisai, Wanwisa
- Supasa, Piyada
- Liu, Chang
- López-Camacho, César
- Slon-Campos, Jose
- Zhao, Yuguang
- Paesen, Guido C.
- Grimes, Jonathan M.
- Antson, Alfred A.
- Bayfield, Oliver W.
- Hawkins, Dorothy E. D. P.
- Ker, De-Sheng
- Wang, Beibei
- Subramaniam, Krishanthi
- Thomson, Paul
- Zhang, Ping
- Dold, Christina
- Ratcliff, Jeremy
- Simmonds, Peter
- de Silva, Thushan
- Wellington, Dannielle
- Rajapaksa, Ushani
- Chen, Yi-Ling
- Paes, Wayne
- Borrow, Persephone
- Kessler, Benedikt M.
- Fry, Jeremy W.
- Ansari, M. Azim
- Zhang, Yonghong
- Ho, Ling-Pei
- Cornall, Richard J.
- Screaton, Gavin R.
- Mongkolsapaya, Juthathip
- Knight, Julian C.
- Venue
- Nature Immunology
- Published
- 2020-09-04
- Volume
- 21
- Issue
- 11
- Pages
- 1336-1345
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7611020
- OpenAlex
- W3082438395
- Cited by
- 1,179
- References
- 42
- Citations by year
- 2026: 41 · 2025: 68 · 2024: 118 · 2023: 171 · 2022: 291 · 2021: 398 · 2020: 91
- FWCI
- 30.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Immunology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (acceptedVersion)
- PubMed Central (submittedVersion)
- Funders
- RCUK | Medical Research Council (MC_PC_19059)
- Chinese Academy of Medical Sciences (2018-I2M-2-002)
- China Scholarship Council
- Wellcome Trust (205228/Z/16/Z, 110058/Z/15/Z, 215091/Z/18/Z, 095541/A/11/Z, award 206377 to AAA)
- DH | NIHR | Health Services Research Programme (NIHR200907, CO-CIN-01)
- University of Liverpool
- University of Oxford
- University of Edinburgh
- DH | National Institute for Health Research (NIHR200927 /WHRG_P82523, NIHR201385 / WHRR P84026, NIHR200907)
- Imperial College London (IS-BRC-1215-20013)
- Worthing Hospital
- Oxford University Hospitals NHS Trust
- National Institutes of Health, National Key R&D Program of China
- University of York
- ProImmune Ltd
- Bill and Melinda Gates Foundation (MC_PC_19059)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell memory, CD4+ T cells, CD8+ T cells, epitope mapping, immunodominant epitopes, spike protein, disease severity, convalescent patients, central memory T cells, effector memory T cells, antiviral immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
